# Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

> **NCT04178174** · PHASE3 · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 360 (estimated)

## Conditions studied

- Head and Neck Cancer
- Oropharynx Cancer
- Human Papilloma Virus

## Interventions

- **RADIATION:** SABR boost and de-escalated chemoradiation
- **RADIATION:** Standard chemoradiation

## Key facts

- **NCT ID:** NCT04178174
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-23
- **Primary completion:** 2027-12
- **Final completion:** 2029-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04178174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04178174, "Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04178174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*